Envista Holdings Corporation (NYSE:NVST - Get Free Report) has received an average recommendation of "Hold" from the fifteen brokerages that are presently covering the stock, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $20.9231.
NVST has been the topic of a number of research reports. Morgan Stanley boosted their price target on Envista from $16.00 to $17.00 and gave the company an "equal weight" rating in a report on Friday, August 1st. Wells Fargo & Company boosted their target price on Envista from $17.00 to $19.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. Stifel Nicolaus upped their price target on Envista from $24.00 to $25.00 and gave the stock a "buy" rating in a research report on Friday, August 1st. Mizuho lifted their price objective on shares of Envista from $15.00 to $18.00 and gave the company an "underperform" rating in a report on Friday, August 1st. Finally, Piper Sandler boosted their price objective on shares of Envista from $17.00 to $19.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st.
Get Our Latest Stock Analysis on Envista
Institutional Investors Weigh In On Envista
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. UMB Bank n.a. grew its holdings in shares of Envista by 214.4% in the 1st quarter. UMB Bank n.a. now owns 2,094 shares of the company's stock valued at $36,000 after acquiring an additional 1,428 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock valued at $44,000 after purchasing an additional 949 shares during the last quarter. EverSource Wealth Advisors LLC grew its stake in Envista by 378.0% in the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company's stock valued at $47,000 after purchasing an additional 1,909 shares in the last quarter. Parallel Advisors LLC grew its stake in Envista by 100.1% in the second quarter. Parallel Advisors LLC now owns 2,792 shares of the company's stock valued at $55,000 after purchasing an additional 1,397 shares in the last quarter. Finally, Palouse Capital Management Inc. increased its position in shares of Envista by 14.4% during the 1st quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company's stock worth $163,000 after purchasing an additional 1,186 shares during the last quarter.
Envista Stock Up 2.4%
Shares of NVST stock opened at $21.29 on Friday. Envista has a 12-month low of $14.22 and a 12-month high of $23.00. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46. The firm has a fifty day moving average of $20.44 and a 200-day moving average of $18.59. The company has a market capitalization of $3.54 billion, a price-to-earnings ratio of 66.52, a P/E/G ratio of 1.11 and a beta of 0.99.
Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.24 by $0.02. The business had revenue of $682.10 million for the quarter, compared to analysts' expectations of $638.21 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. The firm's revenue was up 7.7% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.11 EPS. Envista has set its FY 2025 guidance at 1.050-1.15 EPS. As a group, equities research analysts predict that Envista will post 1 earnings per share for the current fiscal year.
Envista Company Profile
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.